Alpha Teknova Inc Market Cap ($205.34 Million)
Market Cap & Net Worth: Alpha Teknova Inc (TKNO)
Alpha Teknova Inc market cap. Alpha Teknova Inc (NASDAQ:TKNO) has a market capitalization of $205.34 Million ($205.34 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16264 globally and #3882 in its home market, demonstrating a 3.66% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alpha Teknova Inc's stock price $7.37 by its total outstanding shares 53614028 (53.61 Million). Also see cash efficiency ratio of Alpha Teknova Inc for how efficiently the company converts equity into cash flow.
Alpha Teknova Inc Market Cap History (2021–2026)
Alpha Teknova Inc market cap history from 2021 to 2026. Data shows change from $1.10 Billion to $395.14 Million (-20.36% CAGR). Check Alpha Teknova Inc (TKNO) stock price for real-time trading data and today's change.
Index Memberships
Alpha Teknova Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.01% | #441 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #1596 of 3165 |
|
NASDAQ Biotechnology
NBI
|
$1.84 Trillion | 0.01% | #222 of 263 |
Weight: Alpha Teknova Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alpha Teknova Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alpha Teknova Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore TKNO net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
5.03x
Alpha Teknova Inc's market cap is 5.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.10 Billion | $36.89 Million | -$9.80 Million | 29.76x | N/A |
| 2022 | $302.38 Million | $41.42 Million | -$47.47 Million | 7.30x | N/A |
| 2023 | $199.98 Million | $36.68 Million | -$36.78 Million | 5.45x | N/A |
| 2024 | $447.68 Million | $37.74 Million | -$26.75 Million | 11.86x | N/A |
| 2025 | $203.73 Million | $40.52 Million | -$17.26 Million | 5.03x | N/A |
Competitor Companies of TKNO by Market Capitalization
Companies near Alpha Teknova Inc in the global market cap rankings as of November 5, 2026. Also see Alpha Teknova Inc balance sheet assets for a full breakdown of the balance sheet.
Key companies related to Alpha Teknova Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Alpha Teknova Inc (2021–2026)
Market capitalization of Alpha Teknova Inc from 2021 to today. Between 2021 and today, Alpha Teknova Inc's market cap moved from $1.10 Billion to $ 395.14 Million, with a yearly change of -20.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $395.14 Million | +93.95% |
| 2025 | $203.73 Million | -54.49% |
| 2024 | $447.68 Million | +123.86% |
| 2023 | $199.98 Million | -33.87% |
| 2022 | $302.38 Million | -72.46% |
| 2021 | $1.10 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Alpha Teknova Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $205.34 Million USD |
| MoneyControl | $205.34 Million USD |
| MarketWatch | $205.34 Million USD |
| marketcap.company | $205.34 Million USD |
| Reuters | $205.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more